Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Comment by Pepperoni222222on Jun 09, 2021 3:09pm
85 Views
Post# 33356503

RE:RE: US delta variant could become dominant as vacc rate Drop

RE:RE: US delta variant could become dominant as vacc rate Drop

Getting a COVID-19 vaccine is a personal choice. Which l will not comment on. I don’t think testing is going away. With longer duration from vaccination, say 8 to 10 months, could a vaccinated person transmit the virus to somebody who is susceptible? So scientists  continue to ask the question, does a vaccinated person have such low risk (of being infected) that we don’t need to evaluate if they’re positive before they interact with a vulnerable individual? 

 

I believe Sona will play a big role in this space with their Saliva V2 test. But that is just my option of course.

<< Previous
Bullboard Posts
Next >>